{"success":true,"data":{"pressRelease":{"id":"141982","rtpr_id":"nWkr40VxQX-20260914","ticker":"CURAS","exchange":"","all_tickers":["CURAS"],"title":"Major Shareholding Notification - ownership restructuring - related party transaction","author":"Cision","published_at":"2026-09-14T05:00:06.882Z","article_body":"Curasight\nCopenhagen, 14 September 2026 - Curasight A/S (\"Curasight\" or the \"Company\" -\nTICKER: CURAS) announces that the Company has received notification of a\nchange in the ownership structure of an existing major shareholding following\nan internal restructuring. As a result of the restructuring, Curacap Holding\nApS now holds 27.68% of the shares and voting rights in Curasight. This\nannouncement is published in accordance with the applicable major shareholding\nnotification rules of Spotlight Stock Market.\n\nBackground\n\nCo-founder, CMO & CSO Andreas Kjær and CEO & CFO Ulrich Krasilnikoff have\ncompleted an internal restructuring of their ownership interests in Curasight\nby consolidating their holdings into a jointly controlled holding structure.\n\nFor the purpose of the restructuring, Curacap Holding ApS was established as a\nnew holding company. Curacap Holding ApS is the surviving company following a\nmerger with Curacap II ApS, which ceases to exist as a consequence of the\nmerger.\n\nPrior to the restructuring, the relevant shares in Curasight were held through\nCuracap II ApS. Following completion of the restructuring and merger, the\nshares are held by Curacap Holding ApS.\n\nThe restructuring is of a technical nature and does not change the underlying\neconomic ownership of the relevant Curasight shares at the individual\nshareholder level. The purpose of the restructuring is to simplify and\nstreamline the founders' ownership structure and to establish A and B share\nclasses within the new holding structure in order to facilitate potential\nfuture internal generational succession.\n\nTransaction Details\n\nPrior to the restructuring, Andreas Kjær's ownership interest through Curacap\nII ApS represented an indirect holding of 7,365,145 shares in Curasight,\ncorresponding to 14.89% of Curasight's shares and voting rights.\n\nThe ownership interests of Ulrich Krasilnikoff, Susanne Krasilnikoff and Peter\nKrasilnikoff through Curacap II ApS represented an indirect holding of\n6,329,856 shares in Curasight, corresponding to 12.79% of Curasight's shares\nand voting rights.\n\nAs part of the restructuring, the ownership interests in Curacap II ApS were\nexchanged for ownership interests in Curacap Holding ApS, followed by the\nmerger of Curacap II ApS into Curacap Holding ApS, with Curacap Holding ApS as\nthe surviving company.\n\nFollowing completion of the restructuring, the ownership of Curacap Holding\nApS is as follows:\n* Andreas Kjær: 53.78%\n* Krasilnikoff Holding 1 ApS: 25.95%\n* Krasilnikoff Holding ApS: 20.27%\nFollowing the transaction, Curacap Holding ApS holds 13,695,001 shares in\nCurasight A/S, corresponding to approximately 27.68% of the Company's shares\nand voting rights.\n\nGovernance Arrangements\n\nCuracap Holding ApS is jointly controlled by Andreas Kjær and Ulrich\nKrasilnikoff pursuant to the governance arrangements between the shareholders.\n\nThe shareholders have agreed that all material decisions concerning Curacap\nHolding ApS require the unanimous approval of Andreas Kjær and Ulrich\nKrasilnikoff. Accordingly, both parties have equal influence over material\ndecisions relating to the combined shareholding in Curasight.\n\nIn the event of a disagreement that cannot be resolved, either party may\nrequire Curacap Holding ApS to be liquidated in accordance with the agreed\ngovernance arrangements.\n\nMajor Shareholding Notification\n\nAs a result of the restructuring, Curacap Holding ApS holds approximately\n27.68% of the shares and voting rights in Curasight and has therefore crossed\nthe 25% notification threshold pursuant to Section 4.21 of the Spotlight Stock\nMarket Rulebook.\n\nUnder the applicable rules, the Company is required to disclose changes in\nmajor shareholdings when a shareholder's holding reaches, exceeds or falls\nbelow specified thresholds.\n\nThe restructuring has been completed, and this announcement is made in\naccordance with the applicable rules.\n\nImpact on Curasight\n\nThe restructuring is an internal matter between the shareholders and does not\naffect Curasight's operations, strategy or financial position.\n\nThe Company notes that the assessment of whether the restructuring gives rise\nto any separate notification requirements under Danish law is subject to\nconfirmation by the Danish Financial Supervisory Authority.\n\nFor more information regarding Curasight, please contact:\n\nUlrich Krasilnikoff, CEO\n\nE-mail: uk@curasight.com\n\nwww.curasight.com\n\nCurasight is a clinical-stage radiopharmaceutical company pioneering a\nuPAR-targeted theranostic platform that combines precision diagnostic imaging\n(uTRACE®) with 100% corresponding targeted radioligand therapy (uTREAT®).\nCurasight is pioneering first-in-class radioligand therapy targeting uPAR –\nthe pan-tumor functional driver of invasion, angiogenesis, and metastasis. By\nselectively targeting the biological drivers of cancer invasion, angiogenesis\nand metastasis, our approach enables personalized, pan-tumor treatment with\nthe ambition to improve outcomes across aggressive solid tumors.\n\n\nhttps://news.cision.com/curasight/r/major-shareholding-notification---ownership-restructuring---related-party-transaction%2Cc4395286\n\n14-09-26 Curasight Press release - Ownership\n(https://mb.cision.com/Main/19744/4395286/4265736.pdf)\n\n\n\n(c) Cision 2026","article_body_html":"","raw_payload":{"data":{"id":"nWkr40VxQX-20260914","title":"Major Shareholding Notification - ownership restructuring - related party transaction","author":"Cision","ticker":"CURAS","created":"2026-09-14T05:00:06.882Z","tickers":["CURAS"],"exchange":"","article_body":"Curasight\nCopenhagen, 14 September 2026 - Curasight A/S (\"Curasight\" or the \"Company\" -\nTICKER: CURAS) announces that the Company has received notification of a\nchange in the ownership structure of an existing major shareholding following\nan internal restructuring. As a result of the restructuring, Curacap Holding\nApS now holds 27.68% of the shares and voting rights in Curasight. This\nannouncement is published in accordance with the applicable major shareholding\nnotification rules of Spotlight Stock Market.\n\nBackground\n\nCo-founder, CMO & CSO Andreas Kjær and CEO & CFO Ulrich Krasilnikoff have\ncompleted an internal restructuring of their ownership interests in Curasight\nby consolidating their holdings into a jointly controlled holding structure.\n\nFor the purpose of the restructuring, Curacap Holding ApS was established as a\nnew holding company. Curacap Holding ApS is the surviving company following a\nmerger with Curacap II ApS, which ceases to exist as a consequence of the\nmerger.\n\nPrior to the restructuring, the relevant shares in Curasight were held through\nCuracap II ApS. Following completion of the restructuring and merger, the\nshares are held by Curacap Holding ApS.\n\nThe restructuring is of a technical nature and does not change the underlying\neconomic ownership of the relevant Curasight shares at the individual\nshareholder level. The purpose of the restructuring is to simplify and\nstreamline the founders' ownership structure and to establish A and B share\nclasses within the new holding structure in order to facilitate potential\nfuture internal generational succession.\n\nTransaction Details\n\nPrior to the restructuring, Andreas Kjær's ownership interest through Curacap\nII ApS represented an indirect holding of 7,365,145 shares in Curasight,\ncorresponding to 14.89% of Curasight's shares and voting rights.\n\nThe ownership interests of Ulrich Krasilnikoff, Susanne Krasilnikoff and Peter\nKrasilnikoff through Curacap II ApS represented an indirect holding of\n6,329,856 shares in Curasight, corresponding to 12.79% of Curasight's shares\nand voting rights.\n\nAs part of the restructuring, the ownership interests in Curacap II ApS were\nexchanged for ownership interests in Curacap Holding ApS, followed by the\nmerger of Curacap II ApS into Curacap Holding ApS, with Curacap Holding ApS as\nthe surviving company.\n\nFollowing completion of the restructuring, the ownership of Curacap Holding\nApS is as follows:\n* Andreas Kjær: 53.78%\n* Krasilnikoff Holding 1 ApS: 25.95%\n* Krasilnikoff Holding ApS: 20.27%\nFollowing the transaction, Curacap Holding ApS holds 13,695,001 shares in\nCurasight A/S, corresponding to approximately 27.68% of the Company's shares\nand voting rights.\n\nGovernance Arrangements\n\nCuracap Holding ApS is jointly controlled by Andreas Kjær and Ulrich\nKrasilnikoff pursuant to the governance arrangements between the shareholders.\n\nThe shareholders have agreed that all material decisions concerning Curacap\nHolding ApS require the unanimous approval of Andreas Kjær and Ulrich\nKrasilnikoff. Accordingly, both parties have equal influence over material\ndecisions relating to the combined shareholding in Curasight.\n\nIn the event of a disagreement that cannot be resolved, either party may\nrequire Curacap Holding ApS to be liquidated in accordance with the agreed\ngovernance arrangements.\n\nMajor Shareholding Notification\n\nAs a result of the restructuring, Curacap Holding ApS holds approximately\n27.68% of the shares and voting rights in Curasight and has therefore crossed\nthe 25% notification threshold pursuant to Section 4.21 of the Spotlight Stock\nMarket Rulebook.\n\nUnder the applicable rules, the Company is required to disclose changes in\nmajor shareholdings when a shareholder's holding reaches, exceeds or falls\nbelow specified thresholds.\n\nThe restructuring has been completed, and this announcement is made in\naccordance with the applicable rules.\n\nImpact on Curasight\n\nThe restructuring is an internal matter between the shareholders and does not\naffect Curasight's operations, strategy or financial position.\n\nThe Company notes that the assessment of whether the restructuring gives rise\nto any separate notification requirements under Danish law is subject to\nconfirmation by the Danish Financial Supervisory Authority.\n\nFor more information regarding Curasight, please contact:\n\nUlrich Krasilnikoff, CEO\n\nE-mail: uk@curasight.com\n\nwww.curasight.com\n\nCurasight is a clinical-stage radiopharmaceutical company pioneering a\nuPAR-targeted theranostic platform that combines precision diagnostic imaging\n(uTRACE®) with 100% corresponding targeted radioligand therapy (uTREAT®).\nCurasight is pioneering first-in-class radioligand therapy targeting uPAR –\nthe pan-tumor functional driver of invasion, angiogenesis, and metastasis. By\nselectively targeting the biological drivers of cancer invasion, angiogenesis\nand metastasis, our approach enables personalized, pan-tumor treatment with\nthe ambition to improve outcomes across aggressive solid tumors.\n\n\nhttps://news.cision.com/curasight/r/major-shareholding-notification---ownership-restructuring---related-party-transaction%2Cc4395286\n\n14-09-26 Curasight Press release - Ownership\n(https://mb.cision.com/Main/19744/4395286/4265736.pdf)\n\n\n\n(c) Cision 2026"},"type":"article","timestamp":"2026-09-14T05:00:06.987303237Z","server_sent_at_ms":1789362006987},"received_at":"2026-09-14T05:00:07.042Z","source_url":"https://news.cision.com/curasight/r/major-shareholding-notification---ownership-restructuring---related-party-transaction%2Cc4395286"},"analysis":{"id":"130818","press_release_id":"141982","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":["Jointly controlled 27.68% founder block with a unanimity requirement — the deadlock clause allows either founder to force liquidation of the holding company","Assessment of separate notification requirements under Danish law is still subject to confirmation by the Danish Financial Supervisory Authority","Related-party transaction involving the CEO/CFO and CMO/CSO, with a dual-class (A/B) share structure introduced at the holding level"],"eventType":"other","narrative":"Curasight received a major shareholding notification after co-founders Andreas Kjær (CMO & CSO) and Ulrich Krasilnikoff (CEO & CFO) consolidated their holdings into the newly established Curacap Holding ApS, which now holds 13,695,001 shares, approximately 27.68% of shares and voting rights, crossing the 25% notification threshold under the Spotlight Stock Market Rulebook.\n\nThe restructuring is technical in nature: Curacap II ApS was merged into Curacap Holding ApS, and the underlying economic ownership of the shares at the individual shareholder level is unchanged. Prior to the restructuring, Kjær indirectly held 7,365,145 shares (14.89%) and the Krasilnikoff family interests held 6,329,856 shares (12.79%).\n\nCuracap Holding ApS is jointly controlled by the two founders, with all material decisions requiring unanimous approval and A/B share classes established to facilitate future generational succession; an unresolved deadlock allows either party to require liquidation of the holding company.\n\nCurasight states the restructuring does not affect its operations, strategy or financial position, though whether it triggers separate notification requirements under Danish law remains subject to confirmation by the Danish Financial Supervisory Authority.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine, technical founder-holding restructuring with no change in economic ownership or company operations — low-signal compliance disclosure for CURAS."},"keyFigures":{"customDimensions":{"combined_stake_percent":"27.68%","kjaer_prior_indirect_stake":"14.89%","kjaer_prior_indirect_shares":7365145,"notification_threshold_crossed":"25% (Spotlight Stock Market Rulebook Section 4.21)","shares_held_by_curacap_holding":13695001,"krasilnikoff_prior_indirect_stake":"12.79%","curacap_holding_internal_ownership":["Andreas Kjær 53.78%","Krasilnikoff Holding 1 ApS 25.95%","Krasilnikoff Holding ApS 20.27%"],"krasilnikoff_prior_indirect_shares":6329856}},"namedEntities":{"people":[{"name":"Andreas Kjær","role":"Co-founder, CMO & CSO of Curasight; co-controller of Curacap Holding ApS"},{"name":"Ulrich Krasilnikoff","role":"CEO & CFO of Curasight; co-controller of Curacap Holding ApS"},{"name":"Susanne Krasilnikoff","role":"Shareholder via Curacap II ApS (Krasilnikoff family)"},{"name":"Peter Krasilnikoff","role":"Shareholder via Curacap II ApS (Krasilnikoff family)"}],"products":["uTRACE®","uTREAT®"],"companies":[{"name":"Curasight A/S","ticker":"CURAS","relationship":"filer/issuer"},{"name":"Curacap Holding ApS","relationship":"new holding company now holding 27.68% of Curasight"},{"name":"Curacap II ApS","relationship":"prior founders' holding vehicle, merged into Curacap Holding ApS and ceases to exist"},{"name":"Krasilnikoff Holding 1 ApS","relationship":"25.95% owner of Curacap Holding ApS"},{"name":"Krasilnikoff Holding ApS","relationship":"20.27% owner of Curacap Holding ApS"},{"name":"Spotlight Stock Market","relationship":"listing exchange whose shareholding notification rules apply"},{"name":"Danish Financial Supervisory Authority","relationship":"regulator pending confirmation of any separate notification requirements"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"This is a technical internal restructuring of the founders' holding vehicles disclosed under major-shareholding notification rules; the release states it does not change underlying economic ownership or affect Curasight's operations, strategy or financial position. Scored 2 rather than 1 because it is a related-party transaction involving the CEO/CFO and CMO/CSO that creates a jointly controlled 27.68% block and remains subject to Danish FSA confirmation."},"tickerRelevance":{"others":[],"primary":"CURAS"},"globalImportance":12,"audienceRelevance":8,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap foreign issuer (Spotlight Stock Market)","eventGravity":"technical ownership restructuring / shareholding notification","relatedParty":true,"economicChange":"none disclosed","issuerAuthored":true,"regulatoryPendency":"Danish FSA confirmation outstanding"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Curasight received a major shareholding notification after co-founders Andreas Kjær (CMO & CSO) and Ulrich Krasilnikoff (CEO & CFO) consolidated their holdings into the newly established Curacap Holding ApS, which now holds 13,695,001 shares, approximately 27.68% of shares and voting rights, crossing the 25% notification threshold under the Spotlight Stock Market Rulebook.\n\nThe restructuring is technical in nature: Curacap II ApS was merged into Curacap Holding ApS, and the underlying economic ownership of the shares at the individual shareholder level is unchanged. Prior to the restructuring, Kjær indirectly held 7,365,145 shares (14.89%) and the Krasilnikoff family interests held 6,329,856 shares (12.79%).\n\nCuracap Holding ApS is jointly controlled by the two founders, with all material decisions requiring unanimous approval and A/B share classes established to facilitate future generational succession; an unresolved deadlock allows either party to require liquidation of the holding company.\n\nCurasight states the restructuring does not affect its operations, strategy or financial position, though whether it triggers separate notification requirements under Danish law remains subject to confirmation by the Danish Financial Supervisory Authority.","key_figures":{"customDimensions":{"combined_stake_percent":"27.68%","kjaer_prior_indirect_stake":"14.89%","kjaer_prior_indirect_shares":7365145,"notification_threshold_crossed":"25% (Spotlight Stock Market Rulebook Section 4.21)","shares_held_by_curacap_holding":13695001,"krasilnikoff_prior_indirect_stake":"12.79%","curacap_holding_internal_ownership":["Andreas Kjær 53.78%","Krasilnikoff Holding 1 ApS 25.95%","Krasilnikoff Holding ApS 20.27%"],"krasilnikoff_prior_indirect_shares":6329856}},"named_entities":{"people":[{"name":"Andreas Kjær","role":"Co-founder, CMO & CSO of Curasight; co-controller of Curacap Holding ApS"},{"name":"Ulrich Krasilnikoff","role":"CEO & CFO of Curasight; co-controller of Curacap Holding ApS"},{"name":"Susanne Krasilnikoff","role":"Shareholder via Curacap II ApS (Krasilnikoff family)"},{"name":"Peter Krasilnikoff","role":"Shareholder via Curacap II ApS (Krasilnikoff family)"}],"products":["uTRACE®","uTREAT®"],"companies":[{"name":"Curasight A/S","ticker":"CURAS","relationship":"filer/issuer"},{"name":"Curacap Holding ApS","relationship":"new holding company now holding 27.68% of Curasight"},{"name":"Curacap II ApS","relationship":"prior founders' holding vehicle, merged into Curacap Holding ApS and ceases to exist"},{"name":"Krasilnikoff Holding 1 ApS","relationship":"25.95% owner of Curacap Holding ApS"},{"name":"Krasilnikoff Holding ApS","relationship":"20.27% owner of Curacap Holding ApS"},{"name":"Spotlight Stock Market","relationship":"listing exchange whose shareholding notification rules apply"},{"name":"Danish Financial Supervisory Authority","relationship":"regulator pending confirmation of any separate notification requirements"}],"dollarAmounts":[]},"model_name":"glm-5.3-flash","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-14T05:00:53.444Z","global_importance":12,"audience_relevance":8,"importance_components":{"tickerTier":"micro-cap foreign issuer (Spotlight Stock Market)","eventGravity":"technical ownership restructuring / shareholding notification","relatedParty":true,"economicChange":"none disclosed","issuerAuthored":true,"regulatoryPendency":"Danish FSA confirmation outstanding"}},"durationMs":46386,"modelName":"glm-5.3-flash"}}